Rotavirus surveillance in Australia

Authors

  • Kate A Ward Communicable Diseases Branch, NSW Health, North Sydney, New South Wales
  • Peter B McIntyre National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Westmead, New South Wales; Discipline of Paediatrics and Child Health and School of Public Health, University of Sydney, New South Wales
  • Carl D Kirkwood Enteric Virus Research Group, Murdoch Childrens Research Institute, Parkville, Victoria
  • Paul W Roche Surveillance Policy and Systems Section, Australian Government Department of Health and Ageing, Canberra, Australian Capital Territory
  • Mark J Ferson Public Health Unit, South Eastern Sydney Illawarra Health, Randwick, New South Wales; School of Public Health & Community Medicine, University of NSW, Kensington, New South Wales
  • Paul G Van Buynder Communicable Disease Control, WA Department of Health, Subiaco, Western Australia
  • April R Roberts-Witteveen Surveillance Policy and Systems Section, Australian Government Department of Health and Ageing, Canberra, Australian Capital Territory; Australian National University, Acton, Australian Capital Territory
  • Alison M Kesson The Children’s Hospital at Westmead and Discipline of Paediatrics and Child Health, The University of Sydney, New South Wales
  • Vicki L Krause Centre for Disease Control, Department of Health and Community Services, Casuarina, Northern Territory
  • Jeremy M McAnulty Communicable Diseases Branch, NSW Health, North Sydney, New South Wales

DOI:

https://doi.org/10.33321/cdi.2008.32.11

Keywords:

rotavirus, surveillance, children, vaccination

Abstract

In Australia, from 1 July 2005 to 30 June 2006, national rotavirus serotype surveillance data indicated that serotype G1 was the most dominant serotype representing 40% of all strains. Serotype G1 continues to be the most frequently reported serotype worldwide and has been the most common Australian serotype, for all but two years since 1999.

Downloads

Download data is not yet available.

References

Parashar UD, Bresee JS, Gentsch JR, Glass RI. Rotavirus. Emerg Infect Dis 1998;4:561–570.

Parashar UD, Gibson CJ, Bresse JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006;12:304–306.

Galati JC, Harsley S, Richmond P, Carlin JB. The burden of rotavirus-related illness among young children on the Australian health care system. Aust N Z J Public Health 2006;30:416–421.

Newall AT, MacIntyre R, Wang H, Hull B, Macartney K. Burden of severe rotavirus disease in Australia. Paediatr Child Health 2006;42:521–527.

Glass RI, Parashar UD, Bresee JS, Turcios R, Fischer TK, Widdowson MA, et al. Rotavirus vaccines: current prospects and future challenges. Lancet 2006;368:323–332.

Kirkwood CD, Cannan D, Bogdanovic-Sakran N, Bishop RF, Barnes GL, National Rotavirus Surveillance Group. National Rotavirus Surveillance Program annual report, 2005–06. Commun Dis Intell 2006;30:434–438.

Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354:11–22.

Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z; et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354:23–33.

Centers for Disease Control and Prevention. Updated Guidelines for evaluating public health surveillance systems. MMWR Recomm Rep 2001;50 (RR13):1–35 Available from: http://iier.isciii.es/mmwr/preview/mmwrhtml/rr5013a1.htm

Schultz R. Rotavirus gastroenteritis in the Northern Territory, 1995–2004. Med J Aust 2006;2;185:354–356.

Centers for Disease Control and Prevention. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep 2006;55(RR12):1–13. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5512a1.htm

Health Prevention Agency. Rotavirus surveillance data from England and Wales. Available from: http://www.hpa.org.uk/infections/topics_az/rotavirus/data.htm

Harris JP, Jit M, Cooper D, Edmunds WJ. Evaluating rotavirus vaccination in England and Wales. Part I. Estimating the burden of disease. Vaccine 2007;25:3962–3970.

Landry L. Rotavirus disease in Canada. 7th Canadian Immunization Conference; 3–6 December 2006. Winnipeg, Manitoba, Canada. Available from: http://www.phac-aspc.gc.ca/cnic-ccni/2006/pres/_pdf-mon-lun-dec04/PM/B-Hall-B-Rotavirus/Landry_Rotavirus-disease-in-Canada_Imm-Conference-2006.pdf

Centers for Disease Control and Prevention. Suspension of rotavirus vaccine after reports of intussusception—United States, 1999 [published erratum appears in MMWR Morb Mortal Wkly Rep 2004;53:879]. MMWR Morb Mortal Wkly Rep 2004;53:786–789.

Downloads

Published

01/03/08

How to Cite

Ward, Kate A, Peter B McIntyre, Carl D Kirkwood, Paul W Roche, Mark J Ferson, Paul G Van Buynder, April R Roberts-Witteveen, Alison M Kesson, Vicki L Krause, and Jeremy M McAnulty. 2008. “Rotavirus Surveillance in Australia”. Communicable Diseases Intelligence 32 (March):82-87. https://doi.org/10.33321/cdi.2008.32.11.

Issue

Vol. 32 (2008)

Section

Short report

Categories

License

Copyright (c) 2008 Communicable Diseases Intelligence

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>